Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab

Federico Innocenti, Akram Yazdani, Naim Rashid, Xueping Qu, Fang Shu Ou, Scott Van Buren, Monica M. Bertagnolli, Omar Kabbarah, Charles David Blanke, Alan P. Venook, Heinz Josef Lenz, Benjamin G. Vincent

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab'. Together they form a unique fingerprint.

Medicine & Life Sciences